Home › Studies › PRJNA484031
PRJNA484031 SRP158728

Gut microbiota in rectal cancer patients undergoing FOLFOX

Faeces Genome sequencing

62 fecal samples from low-set rectal cancer patients before and after FOLFOX chemotherapy, comparing treatment responders and nonresponders in an intervention study of gut microbiota. machine-written summary

62 samples · 62 runs · CN · Adult · 2019 · 8.68 Gbp / sample

Sources
✓Sequence archive 248○Abstract / description✓Full text 124✓Supplementary tables 62–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive248 sample values (age, health condition, health condition detail, sex)
○ Abstract / descriptionread; no usable statement
✓ Full text124 sample values (country, location site) · PMC7045296
✓ Supplementary tables62 sample values (subject id)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 country
Age
adult43
elderly19
Condition
colorectal_cancer62
Sex
male45
female17
Country
CN62
Body site
primary62
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 40 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 21 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)this project, 30–100 Gbp: 1 samplesall projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 8.68 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

25 of 37 people sampled more than once (50 samples; median 2, up to 2 per person). Schedule stated by the source: “stool collected before FOLFOX treatment and again after treatment was completed” (time origin: intervention_start).

How longitudinal and relatedness information is derived

Community composition
Phocaeicola 18.5%Bacteroides 15.0%Prevotella 7.7%Roseburia 5.0%Faecalibacterium 4.6%Alistipes 3.3%Lachnospira 2.3%Escherichia 2.0%Porphyromonas 1.8%Mediterraneibacter 1.7%Megamonas 1.6%Parabacteroides 1.5%not assigned to a genus 3.6%other genera 31.5%

Genera, mean relative abundance over 58 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category62 100%
country62 100%62
health_condition62 100%62
subject_id62 100%62
age_at_collection_days62 100%62
detailed_location62 100%
health_condition_detail62 100%62
location_site62 100%62
sex62 100%62
Papers (2)
  • Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX. 2020 PMID 32153743 PMC7045296 own_data
  • <i>Anaerostipes hadrus</i>, a butyrate-producing bacterium capable of metabolizing 5-fluorouracil. 2024 PMID 38470044 PMC11036815 unsure
Details
Archive description

62 fecal samples of low-set rectal cancer patients with FOLFOX treatment. Based on the clinical treatment result, the samples were clustered to R and NR. Analysis the gut microbiota, to illustrate the inter relationship between microbes and clinical results.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult and elderly by sonnet_x2 with confidence 0.68. Assay shotgun_dna.

  • host study.description · “62 fecal samples of low-set rectal cancer patients”
  • body site study.description · “62 fecal samples of low-set rectal cancer patients”
  • life stage study.description · “rectal cancer patients with FOLFOX treatment”
  • life stage sample.attr.age · “62 (n=24/62)”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN09748094age_at_collection_days24471.8R10.70sample.attr.age67
SAMN09748094countryCNR30.70paper.fulltext.methodsChina-Japan Friendship Hospital, 37 low-set rectal cancer patients
SAMN09748094health_conditioncolorectal_cancerR10.85biosample.attribute:isolateLow-rectal cancer with FOLFOX
SAMN09748094health_condition_detailLow-rectal cancer with FOLFOXR10.85biosample.attribute:isolateLow-rectal cancer with FOLFOX
SAMN09748094location_siteChina-Japan Friendship HospitalR30.70paper.fulltext.methodsrecruited, from the China-Japan Friendship Hospital, 37 low-set rectal cancer patients
SAMN09748094sexmaleR10.90sample.attr.sexmale
SAMN09748094subject_id2R20.85paper.supp.Table_S7_Enterotype_information.xlsx[group][Patient number]2
Sequencing

62 runs over 62 samples · mean 9.58 Gbp per run (median 8.68 Gbp, total 593.83 Gbp; 62 runs with a base count) · layout SINGLE 62 · platform ILLUMINA 62 · models HiSeq X Ten (62) · 94% of runs with a Sandpiper profile · first public 2019-09-02

Authors (23)

Li J first · Lyu N · Ma Y · Liu F · Feng Y · Yao L · Hou Z · Song X · Zhao H · Li X · Wang Y · Xiao C · Zhu B last · Liu D first · Xie LS · Lian S · Li K · Yang Y · Wang WZ · Hu S · Liu SJ · Liu C · He Z last

Downloads

PRJNA484031.csv.gz (2.6 KB) · parquet (72.2 KB) — all 62 samples, every field with route and confidence · PRJNA484031_determinations.csv.gz (4.0 KB) — 434 evidence rows

Samples (62 · every field this project has values for · hover a cell for its source)
Loading the sample table…